These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 36081258)

  • 1. Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy.
    Ladopoulos T; Matusche B; Bellenberg B; Heuser F; Gold R; Lukas C; Schneider R
    Neuroimage Clin; 2022; 36():103166. PubMed ID: 36081258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin.
    Pontillo G; Petracca M; Monti S; Quarantelli M; Lanzillo R; Costabile T; Carotenuto A; Tortora F; Elefante A; Morra VB; Brunetti A; Palma G; Cocozza S
    Eur Radiol; 2023 Mar; 33(3):2185-2194. PubMed ID: 36241917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tissue and myelin volumetric analysis in multiple sclerosis at 3T MRI with various in-plane resolutions using synthetic MRI.
    Saccenti L; Andica C; Hagiwara A; Yokoyama K; Takemura MY; Fujita S; Maekawa T; Kamagata K; Le Berre A; Hori M; Hattori N; Aoki S
    Neuroradiology; 2019 Nov; 61(11):1219-1227. PubMed ID: 31209528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.
    Liu C; Edwards S; Gong Q; Roberts N; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):323-30. PubMed ID: 10084530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study.
    Lin X; Blumhardt LD; Constantinescu CS
    Acta Neurol Scand; 2003 Dec; 108(6):401-6. PubMed ID: 14616292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Matter Abnormalities in Multiple Sclerosis Evaluated by Quantitative Synthetic MRI, Diffusion Tensor Imaging, and Neurite Orientation Dispersion and Density Imaging.
    Hagiwara A; Kamagata K; Shimoji K; Yokoyama K; Andica C; Hori M; Fujita S; Maekawa T; Irie R; Akashi T; Wada A; Suzuki M; Abe O; Hattori N; Aoki S
    AJNR Am J Neuroradiol; 2019 Oct; 40(10):1642-1648. PubMed ID: 31515218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.
    Cohen AB; Neema M; Arora A; Dell'oglio E; Benedict RH; Tauhid S; Goldberg-Zimring D; Chavarro-Nieto C; Ceccarelli A; Klein JP; Stankiewicz JM; Houtchens MK; Buckle GJ; Alsop DC; Guttmann CR; Bakshi R
    J Neuroimaging; 2012 Apr; 22(2):122-8. PubMed ID: 21447024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.
    Kitzler HH; Su J; Zeineh M; Harper-Little C; Leung A; Kremenchutzky M; Deoni SC; Rutt BK
    Neuroimage; 2012 Feb; 59(3):2670-7. PubMed ID: 21920444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis.
    Cagol A; Ocampo-Pineda M; Lu PJ; Weigel M; Barakovic M; Melie-Garcia L; Chen X; Lutti A; Calabrese P; Kuhle J; Kappos L; Sormani MP; Granziera C
    Neurol Neuroimmunol Neuroinflamm; 2024 Nov; 11(6):e200299. PubMed ID: 39270143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability.
    Bussas M; El Husseini M; Harabacz L; Pineker V; Grahl S; Pongratz V; Berthele A; Riederer I; Zimmer C; Hemmer B; Kirschke JS; Mühlau M
    Neuroimage Clin; 2022; 34():103006. PubMed ID: 35468568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.
    Bonacchi R; Pagani E; Meani A; Cacciaguerra L; Preziosa P; De Meo E; Filippi M; Rocca MA
    Radiology; 2020 Sep; 296(3):605-615. PubMed ID: 32573387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
    Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
    Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.
    Liu Y; Duan Y; Huang J; Ren Z; Liu Z; Dong H; Weiler F; Hahn HK; Shi FD; Butzkueven H; Barkhof F; Li K
    Eur Radiol; 2018 Jan; 28(1):96-103. PubMed ID: 28667482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
    Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
    JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal loss in the multiple sclerosis spinal cord revisited.
    Petrova N; Carassiti D; Altmann DR; Baker D; Schmierer K
    Brain Pathol; 2018 May; 28(3):334-348. PubMed ID: 28401686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.
    Andelova M; Vodehnalova K; Krasensky J; Hardubejova E; Hrnciarova T; Srpova B; Uher T; Menkyova I; Stastna D; Friedova L; Motyl J; Lizrova Preiningerova J; Kubala Havrdova E; Maréchal B; Fartaria MJ; Kober T; Horakova D; Vaneckova M
    BMC Neurol; 2022 Jul; 22(1):270. PubMed ID: 35854235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
    Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis.
    Tsagkas C; Huck-Horvath A; Cagol A; Haas T; Barakovic M; Amann M; Ruberte E; Melie-Garcia L; Weigel M; Pezold S; Schlaeger R; Kuhle J; Sprenger T; Kappos L; Bieri O; Cattin P; Granziera C; Parmar K
    Mult Scler; 2023 May; 29(6):702-718. PubMed ID: 36550626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.